127 - Next-Generation Therapeutics: Discovering New Agents

Rapid Fire Moderator(s)

• SK

  Sheetal Kandiah, MD MPH

  Associate professor of medicine
  Medicine
  Emory university school of medicine
  Atlanta, GA, United States

Presentations:

• 12:15 PM – 12:20 PM US PT

  In vitro Activity of Gepotidacin against Klebsiella pneumoniae, Including Molecularly Characterized ESBL and Carbapenemase positive Subsets Causing Urinary Tract Infections in the United States (2019-2022)
  

  Rapid Fire Presenter: Rodrigo E. Mendes, PhD (he/him/his) – Element, Iowa City (JMI Laboratories)

  Co-Author: Abigail Scullin, BS – Element Materials Technology/Jones Microbiology Institute

  Co-Author: Hank Kimbrough, PhD – Element Materials Technology/Jones Microbiology Institute

  Co-Author: Cory Hubler, BS – Element Materials Technology/Jones Microbiology Institute

  Co-Author: Renuka Kapoor, PhD – GSK

  Co-Author: Didem Torumkuney, PhD – GSK

  Co-Author: S J Ryan Arends, PhD (he/him/his) – JMI Laboratories / Element
• 12:20 PM – 12:25 PM US PT

  Real-World Effectiveness of Dalbavancin for Invasive Gram-Positive Bacterial Infections
  

  Rapid Fire Presenter: Jake Crocker, PharmD – Prisma Health Upstate

  Co-Author: Caroline Derrick, PharmD (she/her/hers) – University of South Carolina School of Medicine

  Co-Author: Julie Ann Justo, PharmD, MS, FIDSA, BCPS – Dartmouth Hitchcock Medical Center

  Co-Author: P. Brandon Bookstaver, PharmD – Prisma Health Richland - University of South Carolina

  Co-Author: Ismaeel Yunusa, PharmD, PhD – University of South Carolina College of Pharmacy

  Co-Author: Bruce M. Jones, Pharm.D., FIDSA, BCPS – St. Joseph's/Candler Health System

  Co-Author: Bryan White, PharmD, FIDSA – University of Oklahoma Medical Center

  Co-Author: Joseph Sassine, MD – University of Oklahoma Health Sciences Center

  Co-Author: Madeline Belk, PharmD – Huntsville Hospital

  Co-Author: Morgan Pizzuti, PharmD – Prisma Health Richland - University of South Carolina
• 12:25 PM – 12:30 PM US PT

  Activity of Omadacycline Against 35,000 Bacterial Clinical Isolates and Resistant Organism Subsets from Patients in the United States (2019–2023)
  

  Rapid Fire Presenter: Michael D. Huband, BS – Element

  Co-Author: Kelley A. Fedler, BS – Element

  Co-Author: Kelly Wright, PharmD, BCPS – Paratek Pharmaceuticals, Inc.

  Co-Author: Rodrigo E. Mendes, PhD (he/him/his) – Element, Iowa City (JMI Laboratories)

  Co-Author: Mariana Castanheira, PhD – Element
• 12:30 PM – 12:35 PM US PT

  Single-Dose and Repeat Single-Dose Ascending Dose Study Evaluating Safety, Tolerability, and Pharmacokinetics of Subcutaneous and Intramuscular CD388, a Novel Long-acting Drug-Fc Conjugate for Universal Prevention of Seasonal and Pandemic Influenza
  

  Rapid Fire Presenter: Shawn Flanagan, PhD (he/him/his) – Cidara Therapeutics

  Co-Author: Ozlem Equils, MD – Cidara Therapeutics

  Co-Author: Roxana E. Rojas, M.D., Ph.D. – Janssen Research & Development

  Co-Author: Tristan Baguet, PharmD – Janssen R&D

  Co-Author: Sy-Shi Wang, Ph.D. – Janssen Pharmaceutical

  Co-Author: Voon Ong, Executive Director – Cidara Therapeutics

  Co-Author: Taylor Sandison, MD, MPH (he/him/his) – Cidara Therapeutics
• 12:35 PM – 12:40 PM US PT

  Assessment of Body Weight upon PK of Olorofim in Patients with Invasive Mould Infections
  

  Co-Author: Karen Cornelissen, PhD (she/her/hers) – F2G

  Co-Author: John H. Rex, MD – F2G, Limited

  Rapid Fire Presenter: Daniela Zinzi, Infectious Diseases Specialist (she/her/hers) – F2G

  Co-Author: Hal Galbraith, PharmaD – IQVIA Inc

  Co-Author: Howard Burt, PBPK Consultant – Certara UK Ltd (Simcyp Division)
• 12:40 PM – 12:45 PM US PT

  Characteristics and Real-world Outcomes of Patients Administered with Fecal Microbiota, live-jslm for the Prevention of Recurrent Clostridioides difficile Infection (rCDI)
  

  Rapid Fire Presenter: Sahil Khanna, MBBS, MS – Mayo Clinic

  Co-Author: Sanghyuk Seo, PharmD, MS – Ferring Pharmaceuticals, Inc.

  Co-Author: Min Yang, MD, PhD – Analysis Group, Inc.

  Co-Author: Viviana García-Horton, PhD – Analysis Group

  Co-Author: Yipeng Gao, PhD – Analysis Group, Inc.

  Co-Author: Hannah Kim, PhD – Analysis Group, Inc.

  Co-Author: Loren Ormenaj, n/a – Analysis Group, Inc.

  Co-Author: Amy Guo, PhD – Ferring Pharmaceuticals